PolyProx Therapeutics (AgeTech UK) Biomed

Protein homeostasis, targetting protein misfolding. PolyProx Therapeutics is a biotechnology company focused on the discovery and development of a new class of drugs, Polyproxin molecules, to treat cancer and neurodegenerative diseases. Polyproxin molecules are biopharmaceuticals that selectively target disease-causing proteins and use natural cellular pathways to degrade or remove these proteins.
Technology: AgeTech Companies
Industry: UK AgeTech 2020
Headquarters: United Kingdom
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership